[{"NetIncomeLoss_1_Q3_USD":-7763000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":15518000.0,"RestrictedCashCurrent_0_Q3_USD":10000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":11.47,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-88000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":38800000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":14700000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-16563000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":105328000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":-3000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1370600.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":143000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":129000.0,"AssetsCurrent_0_Q3_USD":204151000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":147600000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"IncomeTaxCreditsAndAdjustments_3_Q3_USD":1404000.0,"DueToRelatedPartiesCurrent_0_Q3_USD":2077000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":2486000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":1495000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":131383000.0,"CommonStockSharesIssued_0_Q3_shares":37314873.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_3_Q3_USD":-3966000.0,"Assets_0_Q3_USD":217320000.0,"ShareBasedCompensation_3_Q3_USD":5932000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":5235000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":11.88,"OtherAccountsPayableAndAccruedLiabilities_0_Q3_USD":15518000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":105478000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":7638045.0,"RepaymentsOfLongTermDebt_3_Q3_USD":10524000.0,"DueFromRelatedPartiesCurrent_0_Q3_USD":2789000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":37386881.0,"ResearchAndDevelopmentExpense_3_Q3_USD":55020000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":15995000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":11.47,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":154000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":-585000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-37000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-59000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":1305000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"CommonStockValue_0_Q3_USD":null,"InterestPayableCurrent_0_Q3_USD":2000.0,"DebtInstrumentInterestRateStatedPercentage_0_Q3_pure":0.0785,"DepreciationDepletionAndAmortization_3_Q3_USD":601000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.028,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":120645000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-47131000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-7643000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":32647524.0,"GeneralAndAdministrativeExpense_1_Q3_USD":4891000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":13644000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":12.15,"MarketableSecuritiesCurrent_0_Q3_USD":110349000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":6.82,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-9000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":2486000.0,"Liabilities_0_Q3_USD":47730000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":434603000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":4885000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":83625000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":4371000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-10000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":1566000.0,"IncreaseDecreaseInAccountsPayableTrade_3_Q3_USD":32000.0,"CommonStockSharesAuthorized_0_Q3_shares":90000000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q3_USD":8500000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":4596819.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":133000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":120000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-45959000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-7763000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":5932000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1888000.0,"IncreaseDecreaseInAccountsPayableRelatedParties_3_Q3_USD":815000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-53617000.0,"MarketableSecuritiesNoncurrent_0_Q3_USD":6025000.0,"LiabilitiesCurrent_0_Q3_USD":38563000.0,"AccountsPayableCurrent_0_Q3_USD":2797000.0,"PaymentsOfDebtIssuanceCosts_3_Q3_USD":14000.0,"InterestExpense_3_Q3_USD":471000.0,"InterestExpense_1_Q3_USD":19000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":84085000.0,"NetIncomeLoss_3_Q3_USD":-47264000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":1459000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":19600000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":27000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":11800000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":257714.0,"CashEquivalentsAtCarryingValue_0_Q3_USD":79285000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":38800000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q3_pure":0.21,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3_Q3_pure":0.21,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":128000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":6843000.0,"ProceedsFromDebtNetOfIssuanceCosts_3_Q3_USD":23219000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-20653000.0,"RestrictedCashNoncurrent_0_Q3_USD":450000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":50619000.0,"OperatingIncomeLoss_3_Q3_USD":-45686000.0,"OperatingIncomeLoss_1_Q3_USD":-7772000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_3_Q3_USD":3130000.0,"StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_3_Q3_shares":197588.0,"IncomeTaxesReceivable_0_Q3_USD":535000.0,"IncreaseDecreaseInIncomeTaxesReceivable_3_Q3_USD":517000.0,"InvestmentIncomeInterest_3_Q3_USD":820000.0,"InvestmentIncomeInterest_1_Q3_USD":87000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":16765000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":10.32,"PreferredStockValue_0_Q3_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":7.34,"LiabilitiesAndStockholdersEquity_0_Q3_USD":217320000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":5932000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1888000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1406000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-264925000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":2464699.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":4596819.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":170000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":155000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":346000.0,"CommonStockSharesOutstanding_0_Q3_shares":37314873.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":4112000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":170000.0,"ProfitLoss_3_Q3_USD":-47264000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.21,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.45,"OperatingExpenses_1_Q3_USD":20886000.0,"OperatingExpenses_3_Q3_USD":68664000.0,"StockholdersEquity_0_Q3_USD":169590000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":857000.0,"Ticker":"PTGX","CIK":"1377121","name":"PROTAGONIST THERAPEUTICS, INC","OfficialName":"Protagonist Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"939483174.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201104"}]